Works matching IS 07703198 AND DT 2013 AND VI 32 AND IP 1


Results: 21
    1
    2
    3
    4

    A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis

    Published in:
    Clinical Rheumatology, 2013, v. 32, n. 1, p. 99, doi. 10.1007/s10067-012-2096-z
    By:
    • Chen, Xiao-Xiang;
    • Dai, Qing;
    • Huang, An-Bin;
    • Wu, Hua-Xiang;
    • Zhao, Dong-Bao;
    • Li, Xing-Fu;
    • Hu, Shao-Xian;
    • Yang, Nan-Ping;
    • Tao, Yi;
    • Xu, Jian-Hua;
    • Jiang, Lin-Di;
    • Bao, Chun-De
    Publication type:
    Article
    5
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosis.

    Published in:
    Clinical Rheumatology, 2013, v. 32, n. 1, p. 43, doi. 10.1007/s10067-012-2089-y
    By:
    • Yanaba, Koichi;
    • Asano, Yoshihide;
    • Noda, Shinji;
    • Akamata, Kaname;
    • Aozasa, Naohiko;
    • Taniguchi, Takashi;
    • Takahashi, Takehiro;
    • Ichimura, Yohei;
    • Toyama, Tetsuo;
    • Sumida, Hayakazu;
    • Kuwano, Yoshihiro;
    • Tada, Yayoi;
    • Sugaya, Makoto;
    • Kadono, Takafumi;
    • Sato, Shinichi
    Publication type:
    Article
    19
    20
    21